Cargando…
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study
A large number of daily requests to exclude possible prothrombotic risk factors for coronavirus disease 2019 (COVID-19) vaccines were received. Our aim was to longitudinally evaluate coagulation profiles in a series of healthy subjects who received COVID-19 vaccination and assess hypercoagulability...
Autores principales: | Campello, Elena, Bulato, Cristiana, Simion, Chiara, Spiezia, Luca, Radu, Claudia Maria, Gavasso, Sabrina, Sartorello, Francesca, Saggiorato, Graziella, Zerbinati, Patrizia, Fadin, Mariangela, Tormene, Daniela, Simioni, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393084/ https://www.ncbi.nlm.nih.gov/pubmed/35253140 http://dx.doi.org/10.1055/a-1788-5206 |
Ejemplares similares
-
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study
por: Campello, Elena, et al.
Publicado: (2021) -
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC
por: Zanetto, Alberto, et al.
Publicado: (2021) -
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19
por: Campello, Elena, et al.
Publicado: (2022) -
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study
por: Campello, Elena, et al.
Publicado: (2020) -
Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections
por: Zanetto, Alberto, et al.
Publicado: (2022)